Beyond serology: clinical and prognostic determinants in patients with dual AQP4-IgG and MOG-IgG seropositivity
Authors:
- Ipek Gungor DoganIDIpek Gungor Dogan
- Sedat SenSSSedat Sen
- Damla Cetinkaya TezerDTDamla Cetinkaya Tezer
- Sude Kendirli AslanSASude Kendirli Aslan
- Haluk GumusHGHaluk Gumus
- Bilge Piri CinarBCBilge Piri Cinar
- Nuray BilgeNBNuray Bilge
- Ozlem EthemogluOEOzlem Ethemoglu
- Ferah KizilayFKFerah Kizilay
- Cavit BozCBCavit Boz
- Murat TerziMTMurat Terzi
- Serkan DemirSDSerkan Demir
- 12 April 2026
- journal article
- research article
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 111, 107198
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Prevalence and incidence of neuromyelitis optica spectrum disorder in Türkiye: A nationwide epidemiologic studyMultiple Sclerosis and Related Disorders, 2025
- Real‐world clinical experience with serum MOG and AQP4 antibody testing by live versus fixed cell‐based assayAnnals of Clinical and Translational Neurology, 2025
- Double hit – A case in point for dual seropositivity to AQP4 and MOG antibodiesJournal of Neuroimmunology, 2023
- The prevalence and clinical phenotype of dual seropositive neuromyelitis optica spectrum disorders at a national reference center in South AsiaMultiple Sclerosis and Related Disorders, 2023
- Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteriaThe Lancet Neurology, 2023
- Clinical significance of anti-SSA/Ro antibody in Neuromyelitis optica spectrum disordersMultiple Sclerosis and Related Disorders, 2022
- Neuromyelitis opticaNature Reviews Disease Primers, 2020
- Coexistence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies in Adult and Pediatric PatientsJAMA Neurology, 2020
- Epidemiologic and Clinical Characteristics of Optic Neuritis in JapanOphthalmology, 2019
- Autoantibody to MOG suggests two distinct clinical subtypes of NMOSDScience China Life Sciences, 2016